FY18 results for HSO were below expectations, with underlying EBITDA falling 4.4% to A$376 million
Healthscope will establish an unlisted REIT holding hospital real estate on a lease back arrangement, HSO will retain 51% interest. The deal should help to unlock over $1 billion.
You're not a member! Trial today
Funds will be used for capital management initiatives, repaying debt and funding future growth.
Healthscope goes ex-div 3.5c on the 6th September.
Healthscope
